MCT1/SLC16A1: Products

MCT1/SLC16A1 is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates, such as lactate and pyruvate, across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. SLC16A1 may be a potential therapeutic target combining antimetabolic and anti-angiogenic activities. SLC16A1 blockers could act as HIF-1 inhibitors leading to anti-angiogenic effects.

Showing 1-5 out of 5 MCT1/SLC16A1 Products

page of 1
Results Per Page
DescriptionApplicationCat#CitationsImages 

AR-C155858


MCT1 and MCT2 inhibitor; inhibits glycolysis in cancer cells
49601  
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Human MCT1/SLC16A1 APC-conjugated Antibody

FlowFAB8275A 
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Human MCT1/SLC16A1 Antibody

FlowMAB8275 
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Human MCT1/SLC16A1 PE-conjugated Antibody

FlowFAB8275P 
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....

Human MCT1/SLC16A1 (NP_001159968) VersaClone cDNA

RDC0533 
View Sizes & Prices
Catalog# Size Price Stock Quantity
Loading Information....
page of 1
Results Per Page